Chemung Financial reported Q2 2026 results showing EPS of $1.82 and continued balance-sheet optimization driving NIM to 3.67%.
Key Highlights:
- Q2 net income $8.8M and EPS $1.82; YTD net income $18.0M and EPS $3.73, signaling improved earnings.
- Net interest margin rose to 3.67% (up 7 bps Q/Q) with yield on earning assets 5.18% and cost of funds 1.67%.
- Total loans $2.367B; annualized YTD loan growth 8.7% with $234.8M loan increase since June 30, 2025.
- Deposits $2.364B, up $93.3M (4.1%) vs. Dec 31, 2025, including $57.4M (9.2%) growth in non‑interest bearing deposits.
- Balance-sheet actions: sold ~$245M AFS securities in June 2025 (pre-tax loss ~$17.5M) and raised $45M subordinated debt to bolster capital.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.